Medically reviewed by Jessica Swirble, PharmDLast updated on April 17, 2025
Drug Information| | |
Premature ejaculation (PE) is a common sexual problem among men with PE.
The atomoxetine market size was valued at USD 384.9 billion in 2023 and is projected to reach USD 494.3 billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 4.2% from 2024 to 2032.
The popularity of atomoxetine can be attributed to several factors, including its efficacy and relatively mild side effects.
The most common side effects of atomoxetine include:
The potential for side effects with atomoxetine is significant due to its interaction with other medications. The interaction can be a cause or effect for PE and underlying health conditions like kidney disease or heart failure.
It's important to consult with a healthcare provider before starting treatment for PE to ensure it effectively manages the condition.
Individuals with underlying health conditions or taking certain medications should monitor their bodies' natural processes and potential side effects. Atomoxetine can interact with these medications and cause adverse effects.
Additionally, certain recreational drugs, like opioids, can affect the way atomoxetine works, posing risks to patients' health.
The use of atomoxetine is not recommended in men with PE who experienced adverse reactions after taking it. It's essential to address any concerns or side effects promptly based on individual health factors.
The global atomoxetine market is expected to continue growing due to the increasing prevalence of PE and the growing awareness of control issues related to PE. However, the market should continue to grow despite challenges like sustaining expansion.
The following drug information is from the global atomoxetine market size. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider because your doctor or another qualified health provider will have no intention of providing you with an accurate and reliable medicine or vaccine information. The images are for reference only, not for guidance purposes.
Last updated on April 17, 2025
Medically reviewed for pharmacy information | |
Atomoxetine is a selective norepinephrine reuptake inhibitor (NRI). It works by increasing levels of norepinephrine in the brain, which helps improve ejaculation control. It is often prescribed for conditions like premature ejaculation (PE) and certain other conditions.
Atomoxetine is used to treat symptoms of benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate gland that can affect men with an enlarged prostate. It works by increasing the level of the hormone testosterone in the body.
The FDA has approved a drug called Atomoxetine to treat premature ejaculation. The use of Atomoxetine in PE is under investigation and is not approved by the FDA.
However, the use of atomoxetine in the treatment of PE is under investigation. It is not approved for use in the treatment of BPH.
Atomoxetine is often used in the treatment of PE to help men achieve and maintain an erection. It can help improve ejaculation control in those with PE and BPH.
The safety and efficacy of using atomoxetine in the treatment of PE has not been established.
Strattera is a medication that is used to treat ADHD. It is a type of stimulant medication, which means it helps with attention and impulse control. Strattera works by blocking the reuptake of norepinephrine, a chemical in the brain that controls attention, memory, and impulse control. It can be taken in tablet form, and it can be taken as an oral medication. Strattera is often prescribed for children aged 12 years and older. Strattera has a long history of use, and it has been widely prescribed as a treatment for ADHD.
The active ingredient in Strattera is Atomoxetine, which is also sold under the brand name Strattera. Strattera works by increasing norepinephrine levels in the brain, which can help in managing ADHD symptoms. It can also be used alongside other medications for treating ADHD.
Strattera is not approved for children under 12 years old. It is also not suitable for people of Asian descent or those with a history of heart conditions.
Strattera belongs to a group of medications called stimulants. It is typically used for the treatment of ADHD, or as a first-line treatment for Attention Deficit Hyperactivity Disorder (ADHD). The medication works by blocking the reuptake of norepinephrine, a chemical in the brain that controls attention, memory, and impulse control.
It also helps to improve the ability to concentrate and stay focused on tasks. This can be particularly helpful in children who have difficulty staying focused on tasks.
Strattera comes as a tablet, and it usually starts to work within 30 minutes. However, some people may need to take it for several days. The effects may last for several hours or longer.
Strattera typically lasts for around two to four weeks, depending on the condition being treated. It is important to remember that Strattera is not addictive, and it should not be used by people who are addicted to the medication.
If a person is taking Strattera for ADHD, they should speak with their doctor first. They will assess their condition and decide on the best course of treatment.
As with any medication, Strattera can cause side effects, although they are generally mild. Common side effects include:
If you experience any of these side effects or notice any other side effects that would be considered acceptable, stop taking Strattera and consult your doctor immediately.
If you are currently taking any of the following medications, stop taking Strattera and contact your doctor right away:
The following is a list of possible side effects from Strattera:
To make sure Strattera is safe for you, you should discuss the following with your doctor:
If you experience any serious side effects, stop taking Strattera and contact your doctor immediately.
Strattera (atomoxetine) and Strattera XR (atomoxetine) are both medications used to treat attention-deficit hyperactivity disorder (ADHD) in adults and children (18 years or above). The medications have been available since the early 1960s and are commonly prescribed by doctors to help treat ADHD and other neuropsychiatric conditions such as depression, anxiety, and obsessive-compulsive disorder.
The most common side effects of Strattera are:
Nausea and vomiting
Dizziness
Headache
Drowsiness
Diarrhea
Flushing
Blurred vision
Stomach cramps
Insomnia
Strattera and Strattera XR are both medications used to treat ADHD in adults and children (18 years or above). ADHD medications are prescribed to help treat ADHD and other conditions related to attention and focus, including impulse control and impulsivity.
Both medications help improve attention and focus, and both may be effective in treating ADHD. However, some people may experience side effects while taking these medications, such as:
Stimulant medications like Strattera
Oral medications like Strattera XR
Combination medications like Strattera
Strattera and Strattera XR are not approved for use in children.
Strattera and Strattera XR are not approved for use in adults.
If you are taking Strattera or Strattera XR and are experiencing side effects while taking them, talk to your doctor.
Strattera and Strattera XR are not approved for treating ADHD in adults and children.
Strattera is not recommended for use in children. However, some doctors use Strattera for treating attention-deficit hyperactivity disorder (ADHD) in adults.
The recommended dose of Strattera is 25 mg to 50 mg (approximately 100 mg) per day for one to three weeks.
Strattera XR may be prescribed for people who have not yet tried and failed to find a suitable dose of the medication.
However, some doctors may prescribe Strattera XR for people who are unable to tolerate or have other medical conditions.
Strattera XR may be prescribed for people who are taking the drug with a known or suspected allergy to atomoxetine. It is not recommended for people who have a known allergy to Atomoxetine because it may increase the risk of side effects such as nausea, dizziness, or fainting.
However, the dose may be reduced if a person has certain medical conditions such as heart disease, low blood pressure, or a history of substance abuse. Some medical conditions, such as:
It is important to note that Strattera XR and atomoxetine do not work together in the same way. Strattera and atomoxetine may work at different times, so it is important to talk with your doctor about the best time to take both medications together.
Strattera XR may cause drowsiness and dizziness while taking Strattera. It may also cause drowsiness when taking Strattera. It is important to note that Strattera and atomoxetine do not work together in the same way.
Strattera XR may also cause an increased risk of suicidal thoughts or behavior.
Strattera is a non-stimulant medication used to treat adults with attention deficit hyperactivity disorder (ADHD).
Unlike stimulants, Strattera is a more effective alternative to stimulants, providing more effective treatment for ADHD symptoms.
Strattera is a non-stimulant medication that is available in generic forms.
Strattera is a non-stimulant medication that is also available as a non-stimulant drug.
Common side effects include mild headaches, dizziness, and restlessness.
Strattera can be used with other ADHD medications. However, some people may have side effects with Strattera.
For more information on Strattera, consult a healthcare provider.
Strattera is not a controlled substance. You should not use Strattera if you have any medical conditions or are on any medications.
If you have questions about Strattera or its uses, consult with your healthcare provider.
Strattera and other ADHD medications may interact with other medications, including certain antidepressants, and may increase the risk of side effects. However, Strattera is not a controlled substance and it is not recommended for long-term use.
Strattera is not considered a controlled substance. It is a non-stimulant medication and should not be used in conjunction with stimulant medications, as well as certain antidepressants.
Strattera is a non-stimulant medication and should not be used with certain medications that increase the risk of side effects. You should not use Strattera if you are taking any of the following medications:
These medications may interact with Strattera. You should inform your healthcare provider if you are taking any of the following medications or are taking any of the following substances:
Stade de France Pharmacy